Readoutin 104d
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. — TQC2731 injection
Phase 3 primary completion: Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps.
- Date
- Mar 2027
- Type
- Readout
- Indication
- Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)